Advertisement
UK markets close in 3 hours 21 minutes
  • FTSE 100

    7,870.92
    +22.93 (+0.29%)
     
  • FTSE 250

    19,410.84
    +70.70 (+0.37%)
     
  • AIM

    744.57
    +1.45 (+0.20%)
     
  • GBP/EUR

    1.1677
    +0.0010 (+0.09%)
     
  • GBP/USD

    1.2471
    +0.0015 (+0.12%)
     
  • Bitcoin GBP

    50,031.91
    -349.43 (-0.69%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CRUDE OIL

    82.09
    -0.60 (-0.73%)
     
  • GOLD FUTURES

    2,395.80
    +7.40 (+0.31%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • DAX

    17,787.49
    +17.47 (+0.10%)
     
  • CAC 40

    8,015.29
    +33.78 (+0.42%)
     

Is There An Opportunity With Tate & Lyle plc's (LON:TATE) 34% Undervaluation?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Does the June share price for Tate & Lyle plc (LON:TATE) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by projecting its future cash flows and then discounting them to today's value. This is done using the Discounted Cash Flow (DCF) model. Don't get put off by the jargon, the math behind it is actually quite straightforward.

Remember though, that there are many ways to estimate a company's value, and a DCF is just one method. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

ADVERTISEMENT

Check out our latest analysis for Tate & Lyle

Is Tate & Lyle fairly valued?

We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate:

10-year free cash flow (FCF) estimate

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Levered FCF (£, Millions)

£184.25

£200.93

£216.68

£238.66

£262.20

£279.63

£293.67

£305.07

£314.48

£322.43

Growth Rate Estimate Source

Analyst x5

Analyst x6

Analyst x6

Analyst x5

Analyst x1

Est @ 6.65%

Est @ 5.02%

Est @ 3.88%

Est @ 3.09%

Est @ 2.53%

Present Value (£, Millions) Discounted @ 6.55%

£172.93

£176.99

£179.14

£185.19

£190.95

£191.13

£188.39

£183.68

£177.72

£171.01

Present Value of 10-year Cash Flow (PVCF)= £1.82b

"Est" = FCF growth rate estimated by Simply Wall St

After calculating the present value of future cash flows in the intial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 10-year government bond rate of 1.2%. We discount the terminal cash flows to today's value at a cost of equity of 6.5%.

Terminal Value (TV) = FCF2029 × (1 + g) ÷ (r – g) = UK£322m × (1 + 1.2%) ÷ (6.5% – 1.2%) = UK£6.1b

Present Value of Terminal Value (PVTV) = TV / (1 + r)10 = £UK£6.1b ÷ ( 1 + 6.5%)10 = £3.25b

The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is £5.07b. In the final step we divide the equity value by the number of shares outstanding. This results in an intrinsic value estimate of £10.9. Compared to the current share price of £7.2, the company appears quite undervalued at a 34% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.

LSE:TATE Intrinsic value, June 5th 2019
LSE:TATE Intrinsic value, June 5th 2019

The assumptions

Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Tate & Lyle as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.5%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Although the valuation of a company is important, it shouldn’t be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. What is the reason for the share price to differ from the intrinsic value? For Tate & Lyle, I've compiled three further aspects you should further research:

  1. Financial Health: Does TATE have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.

  2. Future Earnings: How does TATE's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Are there other high quality stocks you could be holding instead of TATE? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St updates its DCF calculation for every GB stock every day, so if you want to find the intrinsic value of any other stock just search here.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.